CSBR:NASDAQ
Champions Oncology Inc
US$4,77
arrow_upward
+0,42%(+0,020) 1D
11 ພ.ຈ., 11 ໂມງ 18 ນາທີ 31 ວິນາທີ GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4,79
High
US$4,79
Low
US$4,77
Mkt. cap
66,39 ລ້ານ
Avg. vol.
8,97 ພັນ
Volume
2,80 ພັນ
52-wk high
US$8,31
52-wk low
US$4,63
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
Open
US$4,79
High
US$4,79
Low
US$4,77
Mkt. cap
66,39 ລ້ານ
Avg. vol.
8,97 ພັນ
Volume
2,80 ພັນ
52-wk high
US$8,31
52-wk low
US$4,63
EPS
US$-0,08
Beta
0,47
Shares outstanding
13,92 ລ້ານ
No. of employees
217
News stories
From web sources and news partners
Central Oregon Daily
·
42 ນາທີກ່ອນ
S&P 500, Nasdaq rise over 1% as CoreWeave results calm AI spending jitters
The Globe and Mail
·
21 ນາທີກ່ອນ
3 Unstoppable Nasdaq-100 Stocks to Buy in November
The Motley Fool
·
52 ນາທີກ່ອນ
Okta’s Real Opportunity Isn’t Its S&P 500 Spot. It’s AI Agents.
Reuters
·
6 ຊົ່ວໂມງກ່ອນ
Mapping the Market: S&P 500 at risk of further losses
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ນິວເຈີຊີ, ສະຫະລັດ
SectorHealth Care
Industry-
Websitechampionsoncology.com